COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 1250: Articles 12491-12500  | Next

Epidemiological profile of patients with stage 5 chronic kidney disease on dialysis with Covid 19 infection in a Public Hospital-Peru
VENEGAS JUSTINIANO, J. Y., LOZA MUNARRIZ, C., HURTADO ARESTEGUI, A. N.
10.1101/2021.09.30.21264132 — Posted: 2021-10-01
Gout and coronavirus disease-19 (COVID-19): the risk of diagnosis and death in the UK Biobank
Topless, R., Gaffo, A., Stamp, L., Robinson, P., Dalbeth, N., Merriman, T.
10.1101/2021.09.28.21264270 — Posted: 2021-10-01 Discussion: Onsite
Association between time spent with family and loneliness among Japanese workers during the COVID-19 pandemic: a cross-sectional study
Fujii, R., Konno, Y., Tateishi, S., Hino, A., Tsuji, M., Ikegami, K., Nagata, M., Yoshimura, R., Matsuda, S., Fujino, Y.
10.1101/2021.09.30.21264346 — Posted: 2021-10-01
Mental Health and Time Management Behavior among Students During COVID-19 Pandemic: Towards Persuasive Technology Design
Alhasani, M., Alkhawaji, A., Orji, R.
10.1101/2021.10.01.21264409 — Posted: 2021-10-01
Neonatal outcomes of preterm infants born during COVID-19 community lockdowns in Melbourne, Australia
Mulcahy, B., Rolnik, D., Matheson, A., Liu, Y., Palmer, K., Mol, B. W., Malhotra, A.
10.1101/2021.09.29.21264295 — Posted: 2021-10-01
Characteristics associated with COVID-19 vaccination status among staff and faculty of a large, diverse University in Los Angeles.
Nicolo, M., Kawaguchi, E., Ghanem-Uzqueda, A., Kim, A. E., Soto, D., Deva, S., Shanker, K. J., Rogers, C. J., Lee, R., Casagrande, Y., Gilliland, F., Van Orman, S., Klausner, J., Kovacs, A. A. Z., Conti, D. V., Hu, H., Unger, J. B.
10.1101/2021.09.29.21264315 — Posted: 2021-10-01 Discussion: Onsite
Importation Risk Stratification for COVID19 using Quantitative Serology
Williams, D. E.
10.1101/2021.09.29.21264323 — Posted: 2021-10-01
Assessing the Burden of COVID-19 in Developing Countries: Systematic Review, Meta-Analysis, and Public Policy Implications
Levin, A. T., Owusu-Boaitey, N., Pugh, S., Fosdick, B. K., Zwi, A. B., Malani, A., Soman, S., Besancon, L., Kashnitsky, I., Ganesh, S., McLaughlin, A., Song, G., Uhm, R., Meyerowitz-Katz, G.
10.1101/2021.09.29.21264325 — Posted: 2021-10-01
Modelling of COVID-19 pandemic vis-a-vis some socioeconomic factors
Oshinubi, K., rachdi, M., Demongeot, J.
10.1101/2021.09.30.21264356 — Posted: 2021-10-01
Effectiveness of mRNA-1273 against Delta, Mu, and other emerging variants
Bruxvoort, K., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Lee, G. S., Tian, Y., Florea, A., Aragones, M., Tubert, J. E., Takhar, H. S., Ku, J. H., Paila, Y. D., Talarico, C. A., Tseng, H. F.
10.1101/2021.09.29.21264199 — Posted: 2021-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).